Plasminogen Activator Inhibitor-1 Level Correlates with Lipoprotein Subfractions in Obese Nondiabetic Subjects

BACKGROUND: The elevated level of plasminogen activator inhibitor-1 (PAI-1) in obese subjects with metabolic syndrome and in patients with type 2 diabetes is well established. The association of plasma PAI-1 and lipid metabolism is still unclear. The aim of the present study was to determine the rel...

Descripción completa

Detalles Bibliográficos
Autores principales: Somodi, Sándor, Seres, Ildikó, Lőrincz, Hajnalka, Harangi, Mariann, Fülöp, Péter, Paragh, György
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5998167/
https://www.ncbi.nlm.nih.gov/pubmed/30002679
http://dx.doi.org/10.1155/2018/9596054

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5998167/
https://www.ncbi.nlm.nih.gov/pubmed/30002679
http://dx.doi.org/10.1155/2018/9596054

Ejemplares similares